In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
about
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.Pharmacokinetics and Pharmacodynamics of Fosfomycin and its Activity against ESBL-, Plasmid-mediated AmpC- and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model.Determination of the dynamically-linked indices of fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model (HFIM).
P2860
In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
In Vivo Pharmacokinetics and P ...... e, and Pseudomonas aeruginosa.
@en
type
label
In Vivo Pharmacokinetics and P ...... e, and Pseudomonas aeruginosa.
@en
prefLabel
In Vivo Pharmacokinetics and P ...... e, and Pseudomonas aeruginosa.
@en
P2093
P2860
P356
P1476
In Vivo Pharmacokinetics and P ...... ae, and Pseudomonas aeruginosa
@en
P2093
Alexander J Lepak
Brian VanScoy
Daniel S Taylor
Evelyn Ellis-Grosse
Paul G Ambrose
P2860
P356
10.1128/AAC.00476-17
P407
P50
P577
2017-05-24T00:00:00Z